title: Pseudorabies virus glycoprotein B can be used to carry foot and mouth disease antigens in DNA vaccination of pigs.
abstract: To evaluate the feasibility of using pseudorabies virus (PrV) glycoprotein B (gB) as a carrier of foot and mouth disease virus (FMDV) antigens in DNA immunization, FMDV B- and T-cell epitopes were inserted either between the two B-cell epitopes of the N-term subunit of PrV-gB (BT-PrV-gB-N-term construct) or within the B-cell epitope of the C-term subunit of PrV-gB (BT-PrV-gB-C-term construct). Two animal experiments were performed, each with three injections of plasmids 2 weeks apart, followed by a booster inoculation of peptides corresponding to the FMDV epitopes. Control groups of pigs were injected with plasmids encoding either PrV-gB or FMDV-BT, or with empty-pcDNA3. The results of both assays were combined. Significant titers of FMDV neutralizing antibodies were detected after the peptides boost in groups injected with the BT-PrV-gB-C-term construct. Insignificant amounts were detected in groups injected with the BT-PrV-gB-N-term and FMDV-BT constructs. PBMCs from the BT-PrV-gB-N-term groups, isolated after the peptide boost injection, produced IFN-gamma and IL-4 mRNAs in vitro when stimulated with FMDV peptides. This was not observed with the other groups. These results imply that PrV-gB can be used to carry FMDV antigens in a DNA vaccine.
authors.affiliation: Viral Genetics and Biosafety Unit, French Food Safety Agency (Afssa), BP-53, Fr-22440, Ploufragan, France. d.dory@afssa.fr
authors.forename: Daniel
authors.initials: D
authors.lastname: Dory
authors.forename: Michelle
authors.initials: M
authors.lastname: Rémond
authors.forename: Véronique
authors.initials: V
authors.lastname: Béven
authors.forename: Roland
authors.initials: R
authors.lastname: Cariolet
authors.forename: Marija
authors.initials: M
authors.lastname: Backovic
authors.forename: Stephan
authors.initials: S
authors.lastname: Zientara
authors.forename: André
authors.initials: A
authors.lastname: Jestin
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D000956:Antigens, Viral / Q000235:genetics* / Q000276:immunology; D029544:Foot-and-Mouth Disease Virus / Q000235:genetics* / Q000276:immunology; D007117:Immunization, Secondary; D007371:Interferon-gamma / Q000096:biosynthesis; D015847:Interleukin-4 / Q000096:biosynthesis; D007963:Leukocytes, Mononuclear / Q000276:immunology; D009500:Neutralization Tests; D013552:Swine; D019444:Vaccines, DNA / Q000276:immunology*; D014759:Viral Envelope Proteins / Q000235:genetics*; D014764:Viral Proteins / Q000235:genetics / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D000956:Antigens, Viral; D019444:Vaccines, DNA; D014759:Viral Envelope Proteins; D014764:Viral Proteins; D014765:Viral Vaccines; C070915:glycoprotein gII, pseudorabies virus; D015847:Interleukin-4; D007371:Interferon-gamma